TIGIT的分子和结构基础:Nectin-4相互作用,最近发现的途径对癌症免疫治疗至关重要
Namrata Ganguli1, Puja Kumari1, Sagarika Dash1
1School of Bioscience, Indian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.
Biochemical and biophysical research communications
|August 5, 2023
概括
T细胞免疫球蛋白和ITIM域 (TIGIT) 与 nektin-4 相互作用,抑制自然杀手 (NK) 细胞的活性. 了解这种相互作用为向结素-4表达细胞的癌症免疫疗法提供了洞察力.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- T细胞免疫球蛋白和ITIM域 (TIGIT) 是T细胞和NK细胞上的抑制受体.
- TIGIT 与细胞粘附分子,如 nektin-2 和 nektin-like 5 (PVR) 相互作用.
- 尼克-4是一种新发现的TIGIT相关体,抑制NK细胞细胞毒性.
研究的目的:
- 为了阐明TIGIT-nectin-4相互作用的机制.
- 在TIGIT上映射nectin-4结合接口.
- 提供关于在癌症治疗中准这种途径的见解.
主要方法:
- 生物物理实验,包括表面等离子体共振.
- 结构引导的突变发生研究.
主要成果:
- TIGIT 识别了 nectin-4 的膜-远端 ectodomain.
- 这种TIGIT:nectin-4的相互作用比TIGIT:nectin-2的相互作用弱.
- 在TIGIT上绘制了nectin-4的结合界面.
结论:
- 这项研究破译了新型TIGIT-nectin-4相互作用的分子基础.
- 了解这种相互作用对于操纵免疫信号至关重要.
- 这种知识可以帮助开发针对过度表达 nektin-4 的癌症的疗法.
相关概念视频
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Activation of Integrins
3.5K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K


